Originally posted by HOUDINI563
View Post
this HOUDINI scumbag, is nothing but a brainless ass-clown
this piece-of-shlt copied text from Geert Vanden Bossche page on linkedin, showing his veterinary credentials from... get this... back in 1983
but... what his lying piece-of-shlt HOUDINI forgot to tell you, is the huge wall of credentials since 1983 for Geert Vanden Bossche
I will bold the important details... you know... details that prove Vanden Bossche is one of the leading vaccine experts on the planet lol
- Managing Director
Sep 2012 - 20197 years
Europe
Independent vaccine consultant with a long- standing track record in Academia, Vaccine Industry and Global Health (GH); providing support on vaccine project management as well as advice, guidance and expert opinion on preclinical development of vaccines & biologicals, from project selection up to IND.
Assignments include prophylactic and the****utic vaccine projects in Human and Veterinary Vaccine Industry, Small Biotech, Global Health organizations in the US or Europe
My knowledge…
Show more
Head of the Vaccine Development Office
German Centre for Infection Research (DZIF)
Aug 2017 - Dec 20175 months
Cologne, Germany
Spearheading a portfolio of translational vaccine research projects, conducted at German universities and research centres sponsored by DZIF. Holding overall accountability for strategic alignment of translational infection research in support of preclinical and early clinical testing.
Developing a trans-academic translational network for Vaccine development totalling eight universities and research organizations across Germany.
Chief Innovation & Scientific Officer
Nov 2014 - Nov 20162 years 1 month
Huldenberg
II founded Univac as inventor of a new vaccine technology which I subsequently further developed as CSO of the Company. The technology enables the development of universal vaccines educating the host immune system to redirect immune targeting away from canonical antigens to a widely divergent spectrum of vitally vulnerable pathogen-derived ‘self-mimicking’ antigens, irrespective of MHC polymorphism. Although ‘non-self’ and exposed on the surface of infected or pathologically altered cells…
Show more
Program Manager
Global Alliance for Vaccines and Immunisation (GAVI)
Mar 2015 - Mar 20161 year 1 month
Geneva Area, Switzerland
During my term at GAVI, I coordinated GAVI’s Ebola Vaccine Program and contributed to the implementation of an integrated vaccine work plan in collaboration with Global Health Partners (WHO, Bill & Melinda Gates Foundation, CDC, UNICEF), regulators (FDA) and vaccine manufacturers to enable timely deployment or stockpiling of Ebola vaccine candidate(s) that suitably meet the requirements for use in an Ebola epidemic. In this capacity, I also contributed to several workshops aimed at proposing…
Show more
DVM, PhD, adjunct professor
Positions in Academia
Sep 1980 - Sep 201535 years 1 month
Belgium - Germany
- Training in Veterinary Medicine at the faculty Notre-Dame-de-la-Paix and the State University of
Ghent (1980-1983)
- Doctoral degree in Veterinary Medicine from State University of Ghent (1983)
- Postdoctoral training in Equine Medicine and Surgery at the Free University of Berlin, Germany
(1984-1987)
- Postdoctoral Fellowship in Virology at James A. Baker Institute for Animal Health, Cornell
University, Ithaca, NY 14850, USA (Sept 1990- mid 1991)
- Research…
Show more
Senior Program Officer, Global Health, Vaccine Discovery
May 2008 - Jun 20113 years 2 months
Seattle, Washington 98102, USA
Responsible for operating Vaccine Programs (e.g., HIV-1, Malaria, TB, Polio...) and establishing international product development partnerships for immune interventions in Global Health (e.g., with Academia, Biotech Industry, NIH, Welcome Trust, WHO, PATH). Coordinating and spearheading international collaborations and consortia on innovative vaccine approaches and steering multidisciplinary vaccine initiatives
Global Project Director Influenza Vaccines
Solvay Biologicals
Jul 2007 - May 200811 months
Weesp, the Netherlands
Responsible for leading the operational aspects of an interdisciplinary project team including the planning and implementation of adjuvanted Influenza vaccines that enable dose sparing.
Implementation of commercial-scale production of cell-based methods and expansion of Influenza vaccine production capacity such as to meet DHSS (U.S. Department of Human Health Services) contractual requirements (Pandemic Influenza Preparedness Plan)
Director, Research Program Leader and Head of Adjuvants
Aug 2006 - Jul 20071 year
Siena, Italy & Emeryville, USA
Vaccine Research Program/Adjuvant Program responsibilities:
- Project leader of NVD's RSV vaccine project (Respiratory Syncytial Virus)
- Coordinator of preclinical activities on combined seasonal RSV-Influenza vaccine for elderly &
high risk adults
- Responsible for defining and shaping the scope and strategy of NVD's adjuvant and vaccine
delivery technologies including management of NVD’s adjuvant portfolio, opportunity…
Show more
Head of Adjuvant Technologies and Alternative Deliveries, R&D
May 2001 - May 20065 years 1 month
Rixensart, Belgium
- Research Program Leader on Vaccine Formulation Development & Alternative Deliveries and in
charge of biophysical characterization activities on adjuvanted vaccine formulations.
- Coordination and follow-up of extramural contracts & collaboration agreements on new
immunization strategies and innovative vaccine adjuvant, delivery or formulation technologies
(e.g., co-delivery, mucosal, subcutaneous, intradermal immunization)
- Development and validation of vaccine and…
Show more
- GSK Biologicals
6 years 4 months- Senior Project Leader ‘Adolescent Vaccine Projects'
Jun 1998 - May 2001 3 years
Rixensart, Belgium
Major responsibilities:
Project Management on Raw Material Traceability (RAMATRA) and vaccine projects in Late Development, e.g., Herpes Simplex Virus type 2, Hepatitis B, Streptococcus Pneumoniae and Enterotoxic Escherichia Coli (in collaboration with SBL Vaccines, Sweden) - New Biotech Vaccine Development and QC-QA Manager
Feb 1995 - May 1998 3 years 4 months
Rixensart, Belgium
Major responsibilities (3 direct reports; 6 technicians):
- Management and coordination of vaccine product development, optimization as well as validation
of analytical methods in accordance with regulatory requirements or guidelines and vaccine
marketing constraints
- Budget management of all activities related to QC assay development
- Transfer from R&D and further development of new QC-relevant characterization techniques on
new vaccine candidates (e.g.…
Show more
- Senior Project Leader ‘Adolescent Vaccine Projects'
why did that lying shlthead, and all-around scumbag, HOUDINI... need to scroll past those PHENOMENAL credentials, and copy Vanden Bossche first degree from 40 years ago... to make you all believe that Vanden Bossche is a veterinarian ???
you are a desperate crybaby bltch HOUDINI loooooool
GTFOH you lying ass-clown
OIP.oPmtQsIcBaU-yl-rOrsyxQHaFj?pid=ImgDet&rs=1.jpg
Comment